Assessing the impact of a multidimensional approach and an 8-component bundle in reducing incidences of ventilator-associated pneumonia across 35 countries in Latin America, Asia, the Middle East, and Eastern Europe
Copyright © 2023. Published by Elsevier Inc..
BACKGROUND: Ventilator associated pneumonia (VAP) occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
METHODS: We implemented a multidimensional approach and an 8-component bundle in 374 ICUs across 35 low and middle-income countries (LMICs) from Latin-America, Asia, Eastern-Europe, and the Middle-East, to reduce VAP rates in ICUs. The VAP rate per 1000 mechanical ventilator (MV)-days was measured at baseline and during intervention at the 2nd month, 3rd month, 4-15 month, 16-27 month, and 28-39 month periods.
RESULTS: 174,987 patients, during 1,201,592 patient-days, used 463,592 MV-days. VAP per 1000 MV-days rates decreased from 28.46 at baseline to 17.58 at the 2nd month (RR = 0.61; 95% CI = 0.58-0.65; P < 0.001); 13.97 at the 3rd month (RR = 0.49; 95% CI = 0.46-0.52; P < 0.001); 14.44 at the 4-15 month (RR = 0.51; 95% CI = 0.48-0.53; P < 0.001); 11.40 at the 16-27 month (RR = 0.41; 95% CI = 0.38-0.42; P < 0.001), and to 9.68 at the 28-39 month (RR = 0.34; 95% CI = 0.32-0.36; P < 0.001). The multilevel Poisson regression model showed a continuous significant decrease in incidence rate ratios, reaching 0.39 (p < 0.0001) during the 28th to 39th months after implementation of the intervention.
CONCLUSIONS: This intervention resulted in a significant VAP rate reduction by 66% that was maintained throughout the 39-month period.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
|---|---|
| Enthalten in: |
Journal of critical care - 80(2024) vom: 15. Jan., Seite 154500 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 22.01.2024 Date Revised 22.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jcrc.2023.154500 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366188739 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366188739 | ||
| 003 | DE-627 | ||
| 005 | 20240122232011.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcrc.2023.154500 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1267.xml |
| 035 | |a (DE-627)NLM366188739 | ||
| 035 | |a (NLM)38128216 | ||
| 035 | |a (PII)S0883-9441(23)00249-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rosenthal, Victor Daniel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Assessing the impact of a multidimensional approach and an 8-component bundle in reducing incidences of ventilator-associated pneumonia across 35 countries in Latin America, Asia, the Middle East, and Eastern Europe |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.01.2024 | ||
| 500 | |a Date Revised 22.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier Inc. | ||
| 520 | |a BACKGROUND: Ventilator associated pneumonia (VAP) occurring in the intensive care unit (ICU) are common, costly, and potentially lethal | ||
| 520 | |a METHODS: We implemented a multidimensional approach and an 8-component bundle in 374 ICUs across 35 low and middle-income countries (LMICs) from Latin-America, Asia, Eastern-Europe, and the Middle-East, to reduce VAP rates in ICUs. The VAP rate per 1000 mechanical ventilator (MV)-days was measured at baseline and during intervention at the 2nd month, 3rd month, 4-15 month, 16-27 month, and 28-39 month periods | ||
| 520 | |a RESULTS: 174,987 patients, during 1,201,592 patient-days, used 463,592 MV-days. VAP per 1000 MV-days rates decreased from 28.46 at baseline to 17.58 at the 2nd month (RR = 0.61; 95% CI = 0.58-0.65; P < 0.001); 13.97 at the 3rd month (RR = 0.49; 95% CI = 0.46-0.52; P < 0.001); 14.44 at the 4-15 month (RR = 0.51; 95% CI = 0.48-0.53; P < 0.001); 11.40 at the 16-27 month (RR = 0.41; 95% CI = 0.38-0.42; P < 0.001), and to 9.68 at the 28-39 month (RR = 0.34; 95% CI = 0.32-0.36; P < 0.001). The multilevel Poisson regression model showed a continuous significant decrease in incidence rate ratios, reaching 0.39 (p < 0.0001) during the 28th to 39th months after implementation of the intervention | ||
| 520 | |a CONCLUSIONS: This intervention resulted in a significant VAP rate reduction by 66% that was maintained throughout the 39-month period | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Developing countries | |
| 650 | 4 | |a Device-associated infection | |
| 650 | 4 | |a Healthcare-associated infection | |
| 650 | 4 | |a Hospital infection | |
| 650 | 4 | |a Limited resources countries | |
| 650 | 4 | |a Low-income countries | |
| 650 | 4 | |a Network | |
| 650 | 4 | |a Nosocomial infection | |
| 650 | 4 | |a Ventilator-associated pneumonia | |
| 700 | 1 | |a Jin, Zhilin |e verfasserin |4 aut | |
| 700 | 1 | |a Yin, Ruijie |e verfasserin |4 aut | |
| 700 | 1 | |a Sahu, Suneeta |e verfasserin |4 aut | |
| 700 | 1 | |a Rajhans, Prasad |e verfasserin |4 aut | |
| 700 | 1 | |a Kharbanda, Mohit |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Pravin K |e verfasserin |4 aut | |
| 700 | 1 | |a Mishra, Shakti Bedanta |e verfasserin |4 aut | |
| 700 | 1 | |a Chawla, Rajesh |e verfasserin |4 aut | |
| 700 | 1 | |a Arjun, Rajalakshmi |e verfasserin |4 aut | |
| 700 | 1 | |a Sandhu, Kavita |e verfasserin |4 aut | |
| 700 | 1 | |a Rodrigues, Camilla |e verfasserin |4 aut | |
| 700 | 1 | |a Dongol, Reshma |e verfasserin |4 aut | |
| 700 | 1 | |a Myatra, Sheila Nainan |e verfasserin |4 aut | |
| 700 | 1 | |a Mohd-Basri, Mat Nor |e verfasserin |4 aut | |
| 700 | 1 | |a Chian-Wern, Tai |e verfasserin |4 aut | |
| 700 | 1 | |a Bhakta, Arpita |e verfasserin |4 aut | |
| 700 | 1 | |a Bat-Erdene, Ider |e verfasserin |4 aut | |
| 700 | 1 | |a Acharya, Subhash P |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarez, Gustavo Andres |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno, Lina Alejandra Aguilar |e verfasserin |4 aut | |
| 700 | 1 | |a Gomez, Katherine |e verfasserin |4 aut | |
| 700 | 1 | |a da Jimenez-Alvarez, Luisa Fernanda |e verfasserin |4 aut | |
| 700 | 1 | |a Henao-Rodas, Claudia Milena |e verfasserin |4 aut | |
| 700 | 1 | |a Valderrama-Beltran, Sandra Liliana |e verfasserin |4 aut | |
| 700 | 1 | |a Zuniga-Chavarria, Maria Adelia |e verfasserin |4 aut | |
| 700 | 1 | |a Aguirre-Avalos, Guadalupe |e verfasserin |4 aut | |
| 700 | 1 | |a Hernandez-Chena, Blanca Estela |e verfasserin |4 aut | |
| 700 | 1 | |a Sassoe-Gonzalez, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Aleman-Bocanegra, Mary Cruz |e verfasserin |4 aut | |
| 700 | 1 | |a Villegas-Mota, Maria Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a De Moros, Daisy Aguilar |e verfasserin |4 aut | |
| 700 | 1 | |a Castaneda-Sabogal, Alex |e verfasserin |4 aut | |
| 700 | 1 | |a Carreazo, Nilton Yhuri |e verfasserin |4 aut | |
| 700 | 1 | |a Alkhawaja, Safaa |e verfasserin |4 aut | |
| 700 | 1 | |a Agha, Hala Mounir |e verfasserin |4 aut | |
| 700 | 1 | |a El-Kholy, Amani |e verfasserin |4 aut | |
| 700 | 1 | |a Abdellatif-Daboor, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Dursun, Oguz |e verfasserin |4 aut | |
| 700 | 1 | |a Okulu, Emel |e verfasserin |4 aut | |
| 700 | 1 | |a Havan, Merve |e verfasserin |4 aut | |
| 700 | 1 | |a Yildizdas, Dincer |e verfasserin |4 aut | |
| 700 | 1 | |a Deniz, Suna Secil Ozturk |e verfasserin |4 aut | |
| 700 | 1 | |a Guclu, Ertugrul |e verfasserin |4 aut | |
| 700 | 1 | |a Hlinkova, Sona |e verfasserin |4 aut | |
| 700 | 1 | |a Ikram, Aamer |e verfasserin |4 aut | |
| 700 | 1 | |a Tao, Lili |e verfasserin |4 aut | |
| 700 | 1 | |a Omar, Abeer Aly |e verfasserin |4 aut | |
| 700 | 1 | |a Elahi, Naheed |e verfasserin |4 aut | |
| 700 | 1 | |a Memish, Ziad A |e verfasserin |4 aut | |
| 700 | 1 | |a Petrov, Michael M |e verfasserin |4 aut | |
| 700 | 1 | |a Raka, Lul |e verfasserin |4 aut | |
| 700 | 1 | |a Janc, Jarosław |e verfasserin |4 aut | |
| 700 | 1 | |a Horhat-Florin, George |e verfasserin |4 aut | |
| 700 | 1 | |a Medeiros, Eduardo Alexandrino |e verfasserin |4 aut | |
| 700 | 1 | |a Salgado, Estuardo |e verfasserin |4 aut | |
| 700 | 1 | |a Dueñas, Lourdes |e verfasserin |4 aut | |
| 700 | 1 | |a Coloma, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Perez, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Eric Christopher |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of critical care |d 1987 |g 80(2024) vom: 15. Jan., Seite 154500 |w (DE-627)NLM074731068 |x 1557-8615 |7 nnns |
| 773 | 1 | 8 | |g volume:80 |g year:2024 |g day:15 |g month:01 |g pages:154500 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcrc.2023.154500 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 80 |j 2024 |b 15 |c 01 |h 154500 | ||